Jane E. Churpek

3.8k total citations
45 papers, 1.1k citations indexed

About

Jane E. Churpek is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Jane E. Churpek has authored 45 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Hematology, 14 papers in Molecular Biology and 11 papers in Genetics. Recurrent topics in Jane E. Churpek's work include Acute Myeloid Leukemia Research (27 papers), Acute Lymphoblastic Leukemia research (11 papers) and DNA Repair Mechanisms (6 papers). Jane E. Churpek is often cited by papers focused on Acute Myeloid Leukemia Research (27 papers), Acute Lymphoblastic Leukemia research (11 papers) and DNA Repair Mechanisms (6 papers). Jane E. Churpek collaborates with scholars based in United States, Australia and Brazil. Jane E. Churpek's co-authors include Lucy A. Godley, Richard A. Larson, Amy E. DeZern, Emery H. Bresnick, Kiran Tawana, Tom Walsh, Ming K. Lee, Mary‐Claire King, Colin C. Pritchard and Anna Brown and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Jane E. Churpek

40 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jane E. Churpek United States 18 621 360 282 241 223 45 1.1k
Eveline J. Kamping Netherlands 14 378 0.6× 610 1.7× 252 0.9× 229 1.0× 161 0.7× 23 1.2k
Leonie Saft Sweden 16 875 1.4× 298 0.8× 405 1.4× 106 0.4× 85 0.4× 37 1.1k
Otto Krieger Austria 14 1.2k 1.9× 328 0.9× 528 1.9× 146 0.6× 138 0.6× 37 1.5k
Barbara Crescenzi Italy 18 476 0.8× 344 1.0× 235 0.8× 67 0.3× 134 0.6× 55 1.0k
Henrik Lilljebjörn Sweden 22 673 1.1× 588 1.6× 226 0.8× 264 1.1× 116 0.5× 51 1.6k
Ashwin Kishtagari United States 11 564 0.9× 305 0.8× 323 1.1× 221 0.9× 53 0.2× 56 857
Ann‐Kathrin Eisfeld United States 19 563 0.9× 519 1.4× 193 0.7× 303 1.3× 48 0.2× 64 1.0k
Lurdes Zamora Spain 13 328 0.5× 280 0.8× 253 0.9× 110 0.5× 68 0.3× 55 824
Eva Hellström‐Lindberg Sweden 20 1.5k 2.4× 855 2.4× 758 2.7× 156 0.6× 134 0.6× 29 1.9k
Tobias Berg Canada 19 402 0.6× 856 2.4× 231 0.8× 116 0.5× 73 0.3× 60 1.3k

Countries citing papers authored by Jane E. Churpek

Since Specialization
Citations

This map shows the geographic impact of Jane E. Churpek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane E. Churpek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane E. Churpek more than expected).

Fields of papers citing papers by Jane E. Churpek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jane E. Churpek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane E. Churpek. The network helps show where Jane E. Churpek may publish in the future.

Co-authorship network of co-authors of Jane E. Churpek

This figure shows the co-authorship network connecting the top 25 collaborators of Jane E. Churpek. A scholar is included among the top collaborators of Jane E. Churpek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jane E. Churpek. Jane E. Churpek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Basharat, Ahmad, Kristin L. Long, Paola Da Pozzo, et al.. (2025). Clonal Hematopoiesis Prevalence Years Before a Thyroid Cancer Diagnosis: A Case-Control Study. JCO Precision Oncology. 9(9). e2400760–e2400760.
2.
Brunner, Matthew, Michael J. Fallon, Ryan J. Mattison, et al.. (2024). Implementation of and Systems-Level Barriers to Guideline-Driven Germline Genetic Evaluation in the Care of Patients With Myelodysplastic Syndrome and Acute Myeloid Leukemia. JCO Precision Oncology. 8(8). e2300518–e2300518. 1 indexed citations
3.
4.
Berger, Yaniv, Heather Chen, Oliver S. Eng, et al.. (2023). Surgical phenotype of patients with peritoneal mesothelioma and a germline mutation. Cancer. 129(14). 2152–2160. 2 indexed citations
5.
6.
Gao, Xin, Xiaona You, Nathalie Droin, et al.. (2022). Role of ASXL1 in hematopoiesis and myeloid diseases. Experimental Hematology. 115. 14–19. 15 indexed citations
7.
Agarwal, Anupriya, Jane E. Churpek, Nicolas Duployez, et al.. (2022). Validation and clinical application of transactivation assays forRUNX1variant classification. Blood Advances. 6(11). 3195–3200. 4 indexed citations
8.
Veneris, Jennifer, Lei Huang, Jane E. Churpek, Suzanne D. Conzen, & Gini F. Fleming. (2019). Glucocorticoid receptor expression is associated with inferior overall survival independent of BRCA mutation status in ovarian cancer. International Journal of Gynecological Cancer. 29(2). 357–364. 15 indexed citations
9.
Churpek, Jane E. & Emery H. Bresnick. (2019). Transcription factor mutations as a cause of familial myeloid neoplasms. Journal of Clinical Investigation. 129(2). 476–488. 43 indexed citations
10.
Wang, Amy, Howard Weiner, Margaret Green, et al.. (2018). A phase I study of selinexor in combination with high-dose cytarabine and mitoxantrone for remission induction in patients with acute myeloid leukemia. Journal of Hematology & Oncology. 11(1). 4–4. 50 indexed citations
11.
Tawana, Kiran, Michael W. Drazer, & Jane E. Churpek. (2018). Universal genetic testing for inherited susceptibility in children and adults with myelodysplastic syndrome and acute myeloid leukemia: are we there yet?. Leukemia. 32(7). 1482–1492. 36 indexed citations
12.
Brown, Anna, Jane E. Churpek, Luca Malcovati, Hartmut Döhner, & Lucy A. Godley. (2017). Recognition of familial myeloid neoplasia in adults. Seminars in Hematology. 54(2). 60–68. 27 indexed citations
13.
Churpek, Jane E.. (2017). Familial myelodysplastic syndrome/acute myeloid leukemia. Best Practice & Research Clinical Haematology. 30(4). 287–289. 16 indexed citations
14.
Guidugli, Lucia, Amy Knight Johnson, Gorka Alkorta‐Aranburu, et al.. (2017). Clinical utility of gene panel-based testing for hereditary myelodysplastic syndrome/acute leukemia predisposition syndromes. Leukemia. 31(5). 1226–1229. 32 indexed citations
15.
DiNardo, Courtney D., Sarah A. Bannon, Mark J. Routbort, et al.. (2016). Evaluation of Patients and Families With Concern for Predispositions to Hematologic Malignancies Within the Hereditary Hematologic Malignancy Clinic (HHMC). Clinical Lymphoma Myeloma & Leukemia. 16(7). 417–428.e2. 66 indexed citations
16.
Neistadt, Barbara, Rafael Márquez, Amittha Wickrema, et al.. (2016). Identifying Inherited and Acquired Genetic Factors Involved in Poor Stem Cell Mobilization and Donor-Derived Malignancy. Biology of Blood and Marrow Transplantation. 22(11). 2100–2103. 32 indexed citations
17.
Mirza, Muhammad K., et al.. (2014). Spontaneous Hepatic Rupture Associated With Epstein-Barr Virus Negative Aggressive Natural Killer Cell Leukemia. World Journal of Oncology. 5(5-6). 210–213.
18.
Churpek, Jane E. & Richard A. Larson. (2013). The evolving challenge of therapy-related myeloid neoplasms. Best Practice & Research Clinical Haematology. 26(4). 309–317. 56 indexed citations
19.
Churpek, Jane E., Kenan Onel, Olufunmilayo I. Olopade, et al.. (2012). Proposal for the clinical detection and management of patients and their family members with familial myelodysplastic syndrome/acute leukemia predisposition syndromes. Leukemia & lymphoma. 54(1). 28–35. 61 indexed citations
20.
Churpek, Jane E. & Kenan Onel. (2010). Heritability of Hematologic Malignancies: From Pedigrees to Genomics. Hematology/Oncology Clinics of North America. 24(5). 939–972. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eveline J. Kamping Breakdown of academic impact, for papers by Leonie Saft Breakdown of academic impact, for papers by Otto Krieger Breakdown of academic impact, for papers by Barbara Crescenzi Breakdown of academic impact, for papers by Henrik Lilljebjörn Breakdown of academic impact, for papers by Ashwin Kishtagari Breakdown of academic impact, for papers by Ann‐Kathrin Eisfeld Breakdown of academic impact, for papers by Lurdes Zamora Breakdown of academic impact, for papers by Eva Hellström‐Lindberg Breakdown of academic impact, for papers by Tobias Berg
Rankless by CCL
2026